Getting overwhelmed by the news is an everyday struggle for those wishing to stay in touch with the latest news. Our newsletter should make it easier for those interested in pharmacovigilance regulations, advancement in the relevant use of artificial intelligence, and personal growth. Approaching with care, the same as we provide PV services, we thoughtfully pick articles every month to keep you updated.
Generative artificial intelligence, in particular large language models (LLMs), have demonstrated expert-level domain knowledge across several areas of healthcare. Regular use of fish oil supplements might increase, rather than lessen, the risk of first time heart disease and stroke among those in good cardiovascular health. EMA released Sponsors' guide for Transition of trials from EudraCT to CTIS - CTIS Training Programme - Module 23. And much more...
Sponsors' guide: Transition of trials from EudraCT to CTIS - CTIS Training Programme - Module 23
Information on the Member States requirement for the nomination of a pharmacovigilance (PhV) contact person at national level
EMA’s safety committee, PRAC, has recommended the suspension of the marketing authorisations for medicines containing 17-hydroxyprogesterone caproate (17-OHPC) in the European Union (EU).
Generative artificial intelligence, in particular large language models (LLMs), have demonstrated expert-level domain knowledge across several areas of healthcare. We are not yet aware of any robust tests of LLM performance as it relates to the practice of quality improvement (QI) and patient safety (PS), though their native capabilities seem well suited to QI/PS work.
Current drug–drug interaction (DDI) detection methods often miss the aspect of temporal plausibility, leading to false-positive disproportionality signals in spontaneous reporting system (SRS) databases.
Using artificial intelligence, Ludwig Cancer Research scientists have developed a powerful predictive model for identifying the most potent cancer killing immune cells for use in cancer immunotherapies.
Two of the building blocks of a resilient society. And the opposite of the lazy shortcut. The meanings of both clauses change over time…
Regular use of fish oil supplements might increase, rather than lessen, the risk of first time heart disease and stroke among those in good cardiovascular health, but may slow progression of existing poor cardiovascular health and lower the risk of death, suggest the results of a large long term study, published in the open access journal BMJ Medicine. Fish oil is a rich source of omega 3 fatty acids, and as such, is recommended as a dietary preventive to ward off the development of cardiovascular disease.
The World Health Organization (WHO) and STOP, a global tobacco industry watchdog, are launching today “Hooking the next generation,” a report highlighting how the tobacco and nicotine industry designs products, implements marketing campaigns and works to shape policy environments to help them addict the world’s youth.
Pictures used in this newsletter were generated by AI.